MDL | MFCD00242605 |
---|---|
Molecular Weight | 213.28 |
Molecular Formula | C13H15N3 |
SMILES | C1(N2CCNCC2)=NC3=CC=CC=C3C=C1 |
Quipazine is a 5-HT agonist with a K i value of 1.4 nM for displaces [3H]GR65630 from 5-HT3R in rat. Quipazine shows antiviral activity against SARS-CoV-2 with an EC 50 of 31.64 μM. Quipazine behaves as a 5-HT3R agonist in peripheral models. Quipazine can be used for neurological disease research [1] [2] [3] [4] .
Quipazine shows binding efficacy to 5-HT1 and 5-HT2 with K
i
values of 230 nM
[3]
.
Quipazine displaces [3H]GR65630 from 5-HT3R in rat entorhinal cortex with a K
i
value of 1.4 nM
[3]
.
Quipazine shows antagonistic properties on the rat vagus nerve with pIC
50
value of 6.1, 6.49 and 6.17 for 5-HT2, 5-HT1 and inhibition of 5-HT release
[4]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Quipazine (2.5, 5 and 7.5 mg/kg, one dose for once; i.p.) affects dietary self-selection of different macronutrient diets in male and female rats [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)